Zdrowie AI my pitch to investors

Peter Z. Calka | Founder & CEO peter@zdrowieai.com Seed Round: $10M | October 2025 02 The Problem 💰 $4.3 Trillion Annual healthcare spending in USA alone - 60% is preventable with lifestyle changes 😰 1 Billion People Living with metabolic diseases (diabetes, obesity, hypertension) globally 🩸 Painful & Expensive Current monitoring requires finger pricks, costs $200-400/month, only tracks glucose 🚫 No Real-Time Feedback People don't know WHAT specific foods spike their glucose until it's too late Healthcare is reactive, not preventive 03 Our Solution The world's first ingestible nano-sensor ecosystem 🔬 Nano-Sensor "Zdrowie Chip" Swallowable capsule monitors glucose, insulin, lipids, pH, blood pressure internally for 30 days ⌚ Smart Watch Real-Time Alerts Instant notifications when you eat something harmful + AI suggestions for healthier alternatives nearby 🧠 Behavioral AI Erickson NLP Psychological nudging that makes you WANT healthy choices (not shame-based) Prevention > Treatment Comprehensive metabolic intelligence at 1/10th the cost of current solutions 04 How It Works Step 1 Swallow the Nano-Sensor 8mm capsule (size of large vitamin). Safe, biodegradable, lasts 30 days. Step 2 Sensors Activate in Digestive System Monitors 6 biomarkers: glucose, insulin, lipids, pH, pressure, temperature. Powered by stomach acid + RF harvesting. Step 3 Data Streams to Your Smartwatch Wireless transmission every 5 minutes. You see what's happening in your body RIGHT NOW. Step 4 AI Alerts & Behavioral Nudging "Your glucose is spiking! Swap that pastry for this protein bar from the store across the street. You'll feel more energized." Step 5 Doctor Dashboard (Optional) Your physician sees the same data in cloud. Better diagnosis, fewer visits, lower insurance premiums. 05 Market Opportunity $58 Billion Global wearable medical devices market by 2028 (10.9% CAGR) 1B+ People with metabolic syndrome 150M Target patients (diabetes, pre-diabetes) 80M Health optimizers (biohackers) Target Customers 👴 Primary Age 50-70 Diabetes, cholesterol, hypertension. High willingness to pay ($300-500) 💪 Secondary Age 30-50 Fitness enthusiasts, biohackers. Preventive mindset ($200-400) 🏥 B2B Healthcare Systems Insurance companies, hospitals, employers ($100-150/unit bulk) 06 Competitive Advantage Feature Dexcom CGM Apple Watch Levels Health Zdrowie AI Internal Sensing ✗ External patch ✗ Wrist only ✗ External patch ✓ Ingestible Multi-Biomarker ✗ Glucose only ✗ Heart, O2 ✗ Glucose only ✓ 6 markers Monthly Cost $200-300 Free (device $400) $199-400 $1-10 Behavioral AI ✗ ✗ Basic coaching ✓ Erickson NLP Local Recommendations ✗ ✗ ✗ ✓ Products nearby Medical Certification FDA approved Consumer device Uses Dexcom FDA PMA (planned) We're not 10% better. We're 10x better at 1/10th the price. 07 Business Model B2C Direct-to-Consumer Device: $199 one-time Basic: $9.99/month Premium: $29.99/month (nutritionist access) Target: 2M users by Year 5 B2B Healthcare Systems Hospitals: $150/device + $5/patient/month Insurance: $100/device + data licensing Employers: $120/employee/year Target: 500K enterprise users by Year 5 Additional Revenue Streams 📊 Data Licensing Anonymized metabolic data to pharma & research institutions ($2-5M/year) 🛒 Affiliate Commissions 5-10% commission on healthy product recommendations 🏷️ White-Label Platform License technology to other health companies ($1M+ per deal) Unit Economics CAC: $80 | LTV: $1,200 | LTV:CAC = 15:1 🚀 08 3-Phase Roadmap Year 1-2 Phase 1: MVP - App + External Sensors Goal: Validate behavioral AI without nano-sensor Integrate with existing CGM devices (Dexcom API) Launch beta in Poland (5K users) Prove 15%+ HbA1c improvement Investment: $3M | Status: Launching Q2 2026 Year 2-3 Phase 2: Advanced Wearable Patch Goal: Multi-sensor patch + regulatory approval Develop proprietary dermal patch (glucose, lactate, cortisol) Clinical trials + CE Mark (Europe) Scale to 50K users across EU Investment: $8M | Revenue: $15M Year 4-5 Phase 3: Nano-Sensor Launch Goal: Revolutionary ingestible technology Complete nano-capsule R&D + human trials FDA PMA approval (USA market) Global expansion (2M users) Investment: $20M | Revenue: $420M 09 Financial Projections Metric Year 1 Year 2 Year 3 Year 4 Year 5 Users (EOY) 5K 80K 400K 950K 2M Revenue $2M $15M $65M $180M $420M EBITDA -$8M -$5M +$8M +$45M +$125M Gross Margin 40% 55% 65% 68% 70% EBITDA Positive Year 3 - Self-sustaining growth after Series A $420M Revenue Year 5 - Unicorn trajectory ($1B+ valuation) 10 Team 👨‍💼 Peter Z. Calka Founder & CEO [Add background: healthcare tech, consulting, entrepreneurship] 👨‍🔬 CTO (Recruiting)Capitalism is the social system based upon private ownership of the means of production which entails a completely uncontrolled and unregulated economy where all land is privately owned.